SCHEMBL29496180

SCHEMBL29496180

CC(=O)[C@@](N)(CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 3/20 0.38
▸ C3AR1 Q16581 2/20 0.34
▸ NOD1 Q9Y239 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPY4R P50391 5/20 0.33
▸ GNPAT O15228 1/20 0.32
▸ NPY1R P25929 3/20 0.32
▸ NPY2R P49146 3/20 0.32
▸ NPY5R Q15761 3/20 0.32
▸ ITGB3 P05106 1/20 0.31
▸ ITGA2B P08514 1/20 0.31
▸ SHMT1 P34896 1/20 0.31
▸ ALB P02768 2/20 0.31
▸ CTDSP1 Q9GZU7 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8517227 0.88 FOLH1 (0.39) FOLH1C3AR1NOD1SMN1; SMN2NPY4R
SCHEMBL31184339 0.83 FOLH1 (0.39) FOLH1C3AR1NOD1SMN1; SMN2NPY4R
SCHEMBL1724846 0.81 FOLH1 (0.40) FOLH1C3AR1NOD1SMN1; SMN2NPY4R
SCHEMBL4552682 0.81 FOLH1 (0.40) FOLH1C3AR1NOD1SMN1; SMN2NPY4R
SCHEMBL6026003 0.80 FOLH1 (0.49) FOLH1C3AR1NOD1SMN1; SMN2NPY4R
SCHEMBL446929 0.80 FOLH1 (0.49) FOLH1C3AR1NOD1SMN1; SMN2NPY4R
SCHEMBL8678705 0.80 FOLH1 (0.46) FOLH1C3AR1NOD1SMN1; SMN2NPY4R
SCHEMBL468901 0.80 FOLH1 (0.49) FOLH1C3AR1NOD1SMN1; SMN2NPY4R
SCHEMBL30526285 0.80 FOLH1 (0.49) FOLH1C3AR1NOD1SMN1; SMN2NPY4R
SCHEMBL1070699 0.79 ALDH1A1 (0.41) FOLH1C3AR1NOD1SMN1; SMN2NPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112154145-B Piperazine azaspiro derivatives 辉瑞大药厂 2023-10-17 — — CN disclosed
CN-107787322-B Tricyclic compounds and their use as phosphodiesterase inhibitors 辉瑞大药厂 2023-07-07 — — CN disclosed
CN-110944998-B Dihydro-pyrrolo-pyridine derivatives 辉瑞大药厂 2022-08-16 — — CN disclosed
CN-109641898-B 5, 7-dihydro-pyrrolo-pyridine derivatives for the treatment of neurological and neurodegenerative diseases 辉瑞公司 2022-04-08 — — CN disclosed
Send feedback